drugset / Trial / NCT03785756

Efficacy of 300 mg Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars

NCT03785756

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a single centre, randomised, double-blind, double-dummy, parallel group, multiple-dose, active and placebo-controlled efficacy study to evaluate the efficacy and safety of 2×300mg ibuprofen Prolonged Release (PR) tablets in subjects with postoperative dental pain.

Timeline

Start
2019-04-29
Primary completion
2020-02-20
Completion
2020-02-28

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 400 mg Oral
Subject Ibuprofen Small molecule 600 mg Oral

Indications

No indication recorded.